Bringing the fundamentals into focus…
Back to AbbVie Inc.
How AbbVie Inc. stacks up
ABBV · against 7 other Healthcare companies of similar size
Growth
66/ 100
Near the top of its peers.
Ranked #1 of 8 · scores higher than 100% of peers
Bars: peers in each 10-point band of the growth score2 peers with a growth score of 60–69, including ABBV · Click a bar to see the companies
Why growth scores 66?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its earnings per share growth and revenue growth, which are stronger than most Healthcare peers.
- 3-year revenue growth is close to the peer norm. 3-year revenue growth: 4.7% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 62% of peers. Revenue growth: 10.4% vs peer median 6.1%
- faster growth in earnings per share: stronger than 81% of peers. Earnings per share growth: 67.6% vs peer median 9.8%
Metric by metric
Position: dot = ABBV, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ABBV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 8 reported | 10.4% | 7.6% | 100% | 33% | |
| Earnings per share growthHigher is better · 8 reported | 67.6% | 14.7% | 100% | 33% | |
| 3-year revenue growthHigher is better · 8 reported | 4.7% | 6.8% | 43% | 33% |
Ranking by growth score
Top 5 and the companies ranked around ABBV| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 505.4B USD | 66 | 53 | |
| 2 | 285.2B USD | 64 | 63 | |
| 3 | 302.7B USD | 57 | 63 | |
| 4 | 317.9B CHF (≈$365.6B) | 49 | 60 | |
| 5 | 641.4B USD | 48 | 59 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score